Bill Text: TX SB371 | 2021-2022 | 87th Legislature | Introduced
Bill Title: Relating to matching private grants given to enhance additional research activities at public institutions of higher education.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2021-03-09 - Referred to Higher Education [SB371 Detail]
Download: Texas-2021-SB371-Introduced.html
87R611 MM-D | ||
By: Powell | S.B. No. 371 |
|
||
|
||
relating to matching private grants given to enhance additional | ||
research activities at public institutions of higher education. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Section 62.123(a), Education Code, is amended to | ||
read as follows: | ||
(a) An eligible institution that receives gifts or | ||
endowments from private sources in a state fiscal year for the | ||
purpose of enhancing research activities at the institution, | ||
including a gift or endowment for endowed chairs, professorships, | ||
facilities, equipment, program costs, graduate stipends or | ||
fellowships, or undergraduate research, is entitled to receive, out | ||
of funds appropriated for the purposes of the program for that | ||
fiscal year, a matching grant in an amount determined according to | ||
the following rates: | ||
(1) 50 percent of the amount of the gifts and | ||
endowments, if the total amount of gifts and endowments is $100,000 | ||
or more but not more than $999,999; | ||
(2) 75 percent of the amount of the gifts and | ||
endowments, if the total amount of gifts and endowments is $1 | ||
million or more but not more than $1,999,999; or | ||
(3) 100 percent of the amount of the gifts and | ||
endowments, if: | ||
(A) the total amount of gifts and endowments is | ||
$2 million or more; or | ||
(B) the research activities to be enhanced | ||
include, at a level determined by coordinating board rule, research | ||
occurring in any of the following areas: | ||
(i) epidemiology; | ||
(ii) methods of diagnostic medical testing; | ||
(iii) methods of medical treatment; | ||
(iv) the development or delivery of medical | ||
assistive technology or devices; or | ||
(v) the development or delivery of | ||
pharmaceuticals or vaccines. | ||
SECTION 2. This Act takes effect September 1, 2021. |